(B) in the case of a timer that has a scale of irradiation times or milliampere-second values, is such that the ratio of no two consecutive settings exceeds 1.25:1, except for times not greater than 1/20 second, 3 cycles or the equivalent milliampere-second values, and

Mr. Scott Fairley: Now that I understand the point, I think the difference between the internationally protected persons context under the Security Offences Act and what we're talking about here is a difference in scale.

The difficulty arises from the difference between these two timeframes, and this is why we suggest accelerated amortizement systems such as Class 43 status or other refundable grant or loan programs to promote partnerships so that communities, municipalities, urban communities and the private sector will invest and develop such facilities.

Question No. 53 Ms. Kirsty Duncan: With respect to the chronic cerebrospinal venous insufficiency (CCSVI) clinical trial being undertaken by Dr. Traboulse: (a) what milestones are reportable to the government, (i) on what date(s) is reporting expected to occur, (ii) how will this information be communicated to patients, the medical community, and the general public; (b) on what date did each of the trial sites pass ethical review; (c) on what date did recruitment of patients begin for each of the trial sites; (d) how many patients with multiple sclerosis (MS) are being recruited for each site, and how is consistency in diagnosis and treatment being ensured across si ...[+++]tes; (e) who is performing the diagnoses for CCSVI for each site, (i) how is the diagnosis being performed, including, but not limited to, ultrasound and venogram, (ii) how many diagnoses has each person undertaking the diagnosis at each site performed prior to the study, and by whom was each person trained; (f) who is performing the procedures for each site, (i) how is the procedure being performed, including, but not limited to, anesthetic, balloon size, (ii) how many procedures has each person undertaking the procedure at each site performed prior to the study, and by whom was each person trained; (g) what are the selection criteria for the trial, including, but not limited to, type of MS, Expanded Disability Status Scale (EDSS) score, venous abnormality/malformed valve/stenosis, mobility, (i) how do these criteria compare with the international literature, (ii) with how many international studies to date will the selection criteria be analytically comparable; (h) if both progressive and relapsing-remitting forms of MS are to be examined in the trial, how will statistical significance be ensured given that 50 of 100 patients will undergo a “sham” procedure, 25 patients will have a progressive form of the disease, and 25 will have a relapsing-remitting form of the disease, and will people with bo ...

My figure 2, which I'm not going to put up at the moment, because I would use the rest of my time trying to get these two computers to do it—I'll put it up immediately after—just shows the difference between those two lines over time.

The lessons must be thoroughly learnt so that the same mistakes are not made again. One problem is that education and technology function on very different timescales: while it is an inherent feature of technological tools that they must be constantly renewed, education is a long-term process.